Allen Brain Institute to Use ISH in Lou Gehrig Disease Markers Search | GenomeWeb
NEW YORK (GenomeWeb News) – The Allen Institute for Brain Science will perform in situ hybridization services on tissues for the ALS Therapy Development Institute (ALS TDI) to help identify cells linked to gene expression with the hope of developing treatments for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, ALS TDI said today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.